• Accueil >
  • Publications >
  • Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

11 nov. 2021New England Journal of Medicine

DOI : 10.1056/nejmoa2112435

Auteurs

Nicoletta Colombo, Coraline Dubot, Domenica Lorusso, M. Valeria Caceres, Kosei Hasegawa, Ronnie Shapira-Frommer, Krishnansu S. Tewari, Pamela Salman, Edwin Hoyos Usta, Eduardo Yañez, Mahmut Gümüş, Mivael Olivera Hurtado de Mendoza, Vanessa Samouëlian, Vincent Castonguay, Alexander Arkhipov, Sarper Toker, Kan Li, Stephen M. Keefe, Bradley J. Monk